Clinical Trials Directory

Trials / Conditions / Small Cell Carcinoma

Small Cell Carcinoma

15 registered clinical trials studyying Small Cell Carcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingBispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previ
NCT07328490
National Cancer Institute (NCI)Phase 1 / Phase 2
Not Yet RecruitingPenfluridol for Relapsed/Refractory Small Cell Cancers
NCT07206563
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 1 / Phase 2
TerminatedA Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and
NCT05551117
MacroGenicsPhase 2
TerminatedApalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
NCT04926181
Rahul AggarwalPhase 2
RecruitingQuantifying Systemic Immunosuppression to Personalize Cancer Therapy
NCT05621837
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano—
CompletedThe Registry of Oncology Outcomes Associated With Testing and Treatment
NCT04028479
Taproot Health—
CompletedA Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer o
NCT03910660
BioXcel Therapeutics IncPhase 1 / Phase 2
CompletedPaclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma
NCT02881125
University of WashingtonPhase 1
Active Not RecruitingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
NCT02721732
M.D. Anderson Cancer CenterPhase 2
CompletedRRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based
NCT02489903
EpicentRx, Inc.Phase 2
CompletedCisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Ca
NCT01642251
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedHypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer
NCT00907569
AHS Cancer Control AlbertaPhase 2
CompletedCone Beam CT Scanning in Lung and Bladder Cancer.
NCT00469066
AHS Cancer Control Alberta—
CompletedPhase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cance
NCT00466232
HealthPartners InstitutePhase 1
CompletedHypofractionated Radiotherapy for Small Cell Lung Cancer
NCT00469222
AHS Cancer Control AlbertaPhase 1